Heron Therapeutics, Inc.
Veridion Score
Composite trend over time
Why is HRTX moving today?
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for HRTX.
HRTX insider activity
Heron Therapeutics, Inc.
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for HRTX.
HRTX contract awards, year to date.
Public federal awards linked to this ticker.
HRTX lobbying filings, year to date.
Registered lobbying filings matched to Heron Therapeutics, Inc..